{"id":"https://openalex.org/W31661870","doi":null,"title":"Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.","display_name":"Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.","publication_year":2005,"publication_date":"2005-02-01","ids":{"openalex":"https://openalex.org/W31661870","mag":"31661870","pmid":"https://pubmed.ncbi.nlm.nih.gov/15859361"},"language":"en","primary_location":{"id":"pmid:15859361","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15859361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European annals of allergy and clinical immunology","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107836887","display_name":"Gennaro Liccardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087768","display_name":"Ospedale Antonio Cardarelli","ror":"https://ror.org/003hhqx84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210087768"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gennaro Liccardi","raw_affiliation_strings":["Department of Chest Diseases, Division of Pneumology and Allergology A. Cardarelli, Hospital Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chest Diseases, Division of Pneumology and Allergology A. Cardarelli, Hospital Naples, Italy","institution_ids":["https://openalex.org/I4210087768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064373109","display_name":"Antonello Salzillo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonello Salzillo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111695430","display_name":"Amedeo Piccolo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amedeo Piccolo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037101918","display_name":"Gianenrico Senna","orcid":"https://orcid.org/0000-0003-4172-3216","observed_orcids":["https://orcid.org/0000-0003-4172-3216"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gianenrico Senna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088950185","display_name":"Eugenia Piscitelli","orcid":"https://orcid.org/0000-0002-8179-7562","observed_orcids":["https://orcid.org/0000-0002-8179-7562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugenia Piscitelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007680361","display_name":"Maria D\u2019Amato","orcid":"https://orcid.org/0000-0002-5906-5701","observed_orcids":["https://orcid.org/0000-0002-5906-5701"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria D'Amato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059081126","display_name":"Gennaro D\u2019Amato","orcid":"https://orcid.org/0000-0002-0503-9428","observed_orcids":["https://orcid.org/0000-0002-0503-9428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gennaro D'Amato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2008,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.56636923,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"37","issue":"2","first_page":"50","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":1.0},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/adverse-skin-reactions","display_name":"adverse skin reactions","score":0.6779999732971191},{"id":"https://openalex.org/keywords/paracetamol","display_name":"paracetamol","score":0.777999997138977},{"id":"https://openalex.org/keywords/nimesulide","display_name":"nimesulide","score":0.996999979019165},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9649999737739563},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.38600000739097595},{"id":"https://openalex.org/keywords/angioedema","display_name":"angioedema","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9422347545623779},{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.8503062725067139},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.8422393202781677},{"id":"https://openalex.org/C2777570176","wikidata":"https://www.wikidata.org/wiki/Q20994","display_name":"Nimesulide","level":2,"score":0.819419801235199},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.802631139755249},{"id":"https://openalex.org/C2778722691","wikidata":"https://www.wikidata.org/wiki/Q57055","display_name":"Acetaminophen","level":2,"score":0.702054500579834},{"id":"https://openalex.org/C2779252780","wikidata":"https://www.wikidata.org/wiki/Q582687","display_name":"Antipyretic","level":3,"score":0.6808454990386963},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5917584896087646},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.5661708116531372},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5503376126289368},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.5499094724655151},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5210656523704529},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.445341557264328},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3615102767944336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3381456732749939},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.24700292944908142},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10138735175132751},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000082","descriptor_name":"Acetaminophen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000799","descriptor_name":"Angioedema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006969","descriptor_name":"Hypersensitivity, Immediate","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012882","descriptor_name":"Skin Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15859361","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15859361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European annals of allergy and clinical immunology","raw_type":"Clinical Trial"},{"id":"mag:31661870","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15859361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2403063280","https://openalex.org/W2062666424","https://openalex.org/W4312632585","https://openalex.org/W2143330601","https://openalex.org/W7037030884","https://openalex.org/W1992659686","https://openalex.org/W2043682221","https://openalex.org/W2394916246","https://openalex.org/W2008418238","https://openalex.org/W2019285104"],"abstract_inverted_index":{"BACKGROUND:":[0],"Acetaminophen":[1],"(paracetamol--P)":[2],"and":[3,45,71,88,102,159,193,221,246],"Nimesulide":[4],"(N)":[5],"are":[6,30],"widely":[7],"used":[8,238],"analgesic-antipyretic/anti-inflammatory":[9],"drugs.":[10],"The":[11,98,111,169],"rate":[12],"of":[13,55,60,65,100,119,128,131,144,178,206],"adverse":[14,66],"hypersensitivity":[15,85,212],"reactions":[16,68,94,105],"to":[17,69,76,86,95,165,214,236],"these":[18],"agents":[19],"is":[20,38,231],"generally":[21],"low.":[22],"On":[23],"the":[24,53,117,179,207],"contrary":[25],"non-steroidal":[26],"anti-inflammatory":[27],"drugs":[28],"(NSAIDs)":[29],"commonly":[31],"involved":[32],"in":[33,57,108,133,239],"such":[34],"reactions.":[35,168],"Celecoxib":[36],"(CE)":[37],"a":[39,58,125,141,203,232],"novel":[40],"drug,":[41],"with":[42,62,84,90,191],"high":[43],"selectivity":[44],"affinity":[46],"for":[47,153],"COX-2":[48],"enzyme.":[49],"OBJECTIVE:":[50],"We":[51,80],"evaluated":[52],"tolerability":[54],"CE":[56,132,215,230],"group":[59],"patients":[61,83,150,195],"documented":[63,217],"history":[64],"cutaneous":[67],"P":[70,87,101,220,245],"N":[72,89],"associated":[73,93],"or":[74,91,176,184],"not":[75,243],"classic":[77,96],"NSAIDs.":[78,97],"METHODS:":[79],"studied":[81],"9":[82,219],"without":[92],"diagnosis":[99],"N-induced":[103],"skin":[104],"was":[106,113,147,171,189,216],"based":[107],"vivo":[109],"challenge.":[110,121],"placebo":[112,192],"blindly":[114],"administered":[115],"at":[116],"beginning":[118],"each":[120,157],"After":[122,138],"three":[123],"days,":[124,140],"cumulative":[126],"dosage":[127],"200":[129,145],"mg":[130,146],"refracted":[134],"doses":[135],"were":[136,151],"given.":[137],"2-3":[139],"single":[142],"dose":[143],"administered.":[148],"All":[149],"observed":[152,190],"6":[154],"hours":[155,164],"after":[156,162],"challenge,":[158],"controlled":[160],"again":[161],"24":[163],"exclude":[166],"delayed":[167],"challenge":[170],"considered":[172],"positive":[173],"if":[174],"one":[175,200,211],"more":[177],"following":[180],"appeared:":[181],"erythema,":[182],"rush":[183],"urticaria-angioedema.":[185],"RESULTS:":[186],"No":[187],"reaction":[188,213],"eight":[194],"(88.8%)":[196],"tolerated":[197],"CE.":[198],"Only":[199,210],"patient":[201],"developed":[202],"moderate":[204],"angioedema":[205],"lips.":[208],"CONCLUSION:":[209],"among":[218],"N-highly":[222],"NSAIDs":[223],"intolerant":[224],"patients.":[225],"Thus,":[226],"we":[227],"conclude":[228],"that":[229],"reasonably":[233],"safe":[234],"alternative":[235],"be":[237],"subjects":[240],"who":[241],"do":[242],"tolerate":[244],"N.":[247]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}